NBIXNEUROCRINE BIOSCIENCES INCvs its industry peers
A metric-by-metric comparison of NEUROCRINE BIOSCIENCES INC against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX본 종목 | $14.9B#14 | 21.4x#3 | 4.0x#2 | 5.2x#3 | 21.4%#6 | 40.2%#9 | 21.6%#8 | 13.0%#7 | — | — | 5.9%#8 | — |
| VRTX | $141.7B#4 | 32.6x#5 | 7.0x#5 | 11.8x#8 | 8.9%#9 | 838.1%#3 | 34.8%#2 | 19.5%#5 | 25.0%#4 | — | 33.1%#5 | — |
| AMGN | $252.0B#2 | 29.0x#4 | 21.6x#10 | 6.9x#5 | 10.0%#8 | 88.5%#7 | 24.7%#7 | 66.0%#1 | 15.1%#7 | — | 62.9%#2 | 2.0%#1 |
| GILD | $212.0B#3 | — | 16.3x#9 | 7.2x#6 | 2.4%#10 | 1672.9%#2 | 34.0%#3 | 65.3%#2 | 25.7%#3 | — | 47.1%#3 | 1.9%#2 |
| REGN | — | 20.5x#2 | — | — | 1.0%#12 | 2.1%#11 | 24.9%#6 | 13.4%#6 | 9.2%#9 | — | 41.7%#4 | — |
| ARGX | $55.2B#7 | — | — | 1554.5x#13 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 8.8%#7 | — |
| ALNY | $22.1B#13 | 8.6x#1 | 6.1x#4 | 5.9x#4 | 65.2%#3 | 212.8%#4 | 13.5%#10 | 8.7%#9 | 19.3%#6 | — | — | — |
| NTRA | $59.7B#6 | — | 32.8x#11 | 25.9x#9 | 35.9%#5 | -9.3%#12 | -13.4%#12 | -11.4%#11 | -18.0%#10 | — | — | — |
| RVMD | $41.0B#8 | — | 15.7x#8 | — | — | -88.5%#15 | — | -43.4%#13 | — | — | — | — |
| BIIB | $37.5B#9 | 109.8x#8 | 2.5x#1 | 3.8x#1 | 2.2%#11 | -20.8%#13 | 28.7%#5 | 8.7%#8 | 12.3%#8 | 3#3 | 69.6%#1 | — |
| ILMN | $35.7B#10 | 40.6x#6 | 11.3x#6 | 8.2x#7 | -0.7%#13 | 169.5%#5 | 18.6%#9 | 27.0%#3 | 19.9%#5 | 8#1 | — | — |
| MRNA | $88.5B#5 | — | 13.1x#7 | 45.5x#11 | -39.9%#14 | 20.8%#10 | -158.1%#13 | -41.7%#12 | -54.6%#11 | — | — | — |
| INSM | $24.7B#11 | — | 34.0x#12 | 40.7x#10 | 66.7%#2 | -39.7%#14 | -205.6%#14 | -175.8%#14 | -141.2%#12 | 3#3 | — | — |
| ONC | $547.3B#1 | 861.1x#9 | 105.8x#13 | 102.4x#12 | 40.2%#4 | 144.5%#6 | 8.4%#11 | 5.5%#10 | 29.9%#2 | 6#2 | 20.2%#6 | — |
| INCY | $24.5B#12 | 61.4x#7 | 4.3x#3 | 4.8x#2 | 21.2%#7 | 3846.9%#1 | 29.5%#4 | 22.8%#4 | 45.1%#1 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice